Taro Pharmaceutical Industries Ltd.
NYSE: TARO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Uday V. Baldota
- Employees
- 1,554
- Headquarters
- Haifa, Israel
- IPO year
- 1982
- Market cap
- $1.6B
- Website
- https://www.taro.com
Loading TARO…
Loading profile data…Frequently asked questions about TARO
What does Taro Pharmaceutical Industries Ltd. (TARO) do?
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also pro...
Where does TARO trade?
Taro Pharmaceutical Industries Ltd. (TARO) trades on the New York Stock Exchange.
What sector is TARO in?
Taro Pharmaceutical Industries Ltd. (TARO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Taro Pharmaceutical Industries Ltd.?
Uday V. Baldota is the chief executive officer of Taro Pharmaceutical Industries Ltd. (TARO).
Where is Taro Pharmaceutical Industries Ltd. headquartered?
Taro Pharmaceutical Industries Ltd. is headquartered in Israel.
Does TARO pay a dividend?
Taro Pharmaceutical Industries Ltd. (TARO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TARO go public?
Taro Pharmaceutical Industries Ltd. (TARO) completed its initial public offering in 1982.